Ondansetron for Atrial Fibrillation
Phase 4
80
about 2.7 years
18–100
3 sites in IN
What this study is about
Researchers are testing whether ondansetron, a medication used to prevent nausea, can help manage atrial fibrillation (Afib). The trial will involve 80 adults scheduled for an Afib ablation procedure. Participants will be randomly assigned to receive either ondansetron or a placebo for 28 days before the procedure and will have their time in Afib and heart rate monitored.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Ondansetron 8mg
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
ondansetron (5-HT3 receptor antagonist; prevents nausea/vomiting)
injection
Secondary: Adverse effects
Cardiology / Heart